Clinical Trials Directory

Trials / Completed

CompletedNCT02734641

Does Increase in Appetite After Iron Treatment Induced by Ghrelin Hormone

Status
Completed
Phase
Study type
Observational
Enrollment
111 (actual)
Sponsor
HaEmek Medical Center, Israel · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to examine whether iron therapy in patients with intravenous iron deficiency anemia causes an increase in appetite. And whether this increase is mediated by the hormone ghrelin.

Detailed description

Prior to Iron treatment Investigator will sample subject blood for: counting blood, iron sector indices, renal function, electrolytes, and measure the level of ghrelin fasting plasma. In addition, the patient will fill a structured questionnaire that examines appetite levels. participants will be asked to answer a structured questionnaire which will include information on demographics, clinical data (fever, allergies, weight, height) and comorbidities. Additional data on laboratory tests, comorbidities, medication and regular blood and urine cultures results will be taken from the medical file. Iron treatment will be given according to local standard procedure . At the end of the treatment ghrelin levels and questionaire will be retaken . iron deficiency anemia is defined: hemoglobin \<12 gr / dl in women and Hb \<13 gr / dl in men with ferritin \<15 ng / ml.

Conditions

Timeline

Start date
2016-08-01
Primary completion
2017-04-01
Completion
2018-04-17
First posted
2016-04-12
Last updated
2018-12-19

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT02734641. Inclusion in this directory is not an endorsement.

Does Increase in Appetite After Iron Treatment Induced by Ghrelin Hormone (NCT02734641) · Clinical Trials Directory